爵士製藥 JAZZ 深 滬
等待開盤 09-24 09:30:00 美东时间
234.88
-5.690
-2.37%
華盛通- 最 高241.325
- 今 開239.26
- 成交量 79.22万股
- 最 低 231.59
- 昨 收 240.57
- 總市值 152.47亿
- 52周最高 266.375
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 128.80
- 委 比 -97.72%
- 總股本 6491.46万
- 歷史最高 266.375
- 量 比 0.91
- 振 幅 4.05%
- 歷史最低 31.87
- 每 手 1
- 風險率 40.43%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Jazz Pharmaceuticals Refinances Term Loan, Extends Maturities
An announcement from Jazz Pharmaceuticals ( ($JAZZ) ) is now available. On Sept...
今天 04:52
Nvidia-backed AI drugmaker Iambic Therapeutics seeks U.S. listing
Iambic Therapeutics, an AI-driven drug discovery company backed by Nvidia (NVDA), filed for a U.S. initial public offering on Monday, seeking to list on the Nasdaq under the ticker IAM. The San Diego-...
09-22 12:44
Jazz Pharmaceuticals Completes Acquisition of Actio Biosciences
Acquisition adds ABS-1230, a clinical-stage, potential first-in-class precision therapy for KCNT1-related epilepsy Transaction strengthens Jazz's epilepsy pipeline and reinforces its commitm...
09-15 21:00
美股大行评级 | Adobe绩后获多家大行齐升目标价！最高看多至270美元；甲骨文绩后现多空分歧
今日重点评级关注：Ascendiant Capital：维持Outlook Therapeutics"买入"评级，目标价从10美元升至10.5美元；摩根士丹利：维持Aurora Innovation"超配"评级，目标价从14美元升至18美元
09-14 16:05
美股大行评级 | 齐声看好医药股！礼来、强生、默沙东目标价均获上调；小摩大幅上调Meta目标价至820美元
今日重点评级关注：康托·菲茨杰拉德：维持SOL Strategies"超配"评级，目标价从2.8美元升至6.2美元；康托·菲茨杰拉德：维持Sui Group Holdings"超配"评级，目标价从1.7美元升至3.4美元
09-11 14:30
Barclays Maintains Overweight on Jazz Pharmaceuticals, Raises Price Target to $271
Barclays analyst Etzer Darout maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Overweight and raises the price target from $270 to $271.
09-10 21:11
Jazz Pharmaceuticals Completes $1.25 Billion Notes Offering
Jazz Pharmaceuticals ( ($JAZZ) ) just unveiled an announcement. On August 31, 2...
09-01 05:51
Jazz Pharmaceuticals prices upsized $1.1B private debt offering
Jazz Pharmaceuticals (JAZZ) announced the pricing of $1.1B aggregate principal amount of 1.875% exchangeable senior notes due 2032. The offering was upsized from the previously announced offering size...
08-27 16:28
美股大行评级 | 潜在涨幅1849.95%！Ascendiant Capital上调IGC Pharma目标价至6美元，维持"买入"评级；迪克体育、财捷遭多家大行下调目标价
今日重点评级关注：Ascendiant Capital：维持IGC Pharma"买入"评级，目标价从5.5美元升至6美元；Ascendiant Capital：维持Quantum Computing"买入"评级，目标价从30美元升至32美元
08-27 08:37
